Cargando…

Consumers’ adverse drug event reporting via community pharmacists: three stakeholder perception

BACKGROUND: Adverse drug event (ADE) reporting is a significant process to increase consumer care and consumer safety associated with the use of medicines. An in-depth investigation into low ADE reporting by consumers and community pharmacists was undertaken to uncover interventions to improve repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitisopee, Tanattha, Assanee, Jirunya, Sorofman, Bernard A., Watcharadmrongkun, Suntaree
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919562/
https://www.ncbi.nlm.nih.gov/pubmed/35287746
http://dx.doi.org/10.1186/s40545-022-00417-z
_version_ 1784668959036932096
author Kitisopee, Tanattha
Assanee, Jirunya
Sorofman, Bernard A.
Watcharadmrongkun, Suntaree
author_facet Kitisopee, Tanattha
Assanee, Jirunya
Sorofman, Bernard A.
Watcharadmrongkun, Suntaree
author_sort Kitisopee, Tanattha
collection PubMed
description BACKGROUND: Adverse drug event (ADE) reporting is a significant process to increase consumer care and consumer safety associated with the use of medicines. An in-depth investigation into low ADE reporting by consumers and community pharmacists was undertaken to uncover interventions to improve reporting. METHOD: In-depth interviewing of the three parties; consumers, pharmacists and employees of the Pharmacovigilance Center in Thailand, was used to collect the data. They were interviewed about ADE reporting experiences and contributing factors and problems of ADE reporting. Thematic analysis was used to interpret the results. RESULT: The HPVC received few ADE reports from consumers. Most community pharmacists received ADE reports from consumers; however, the Pharmacovigilance Center received few ADE reports from community pharmacists. ADE reporting of community pharmacists and consumers were influenced by many factors which were categorized into four themes which were (1) “Cognition” (awareness, attitude and responsibility); (2) “Reporting process” (complication, competency, information deficiency, feedback, and resource); (3) “Inducer” (service orientation, acquaintanceship, motivation, severity level, regulatory and reward); and (4) “Obstacle” (doubt, belief and prosecution). CONCLUSION: Health professionals should motivate consumers to report ADEs. Building social responsibility and benefits and increasing knowledge of reporting process, channels, and system to both community pharmacists and consumers were recommended. Providing rewards and making community pharmacists feel comfortable to report ADEs by simplifying the ADE form and providing training, guidelines, and an ADR assessment tool can drive them to report ADEs. Feedback to consumers by confirming whether it was ADE and feedback to pharmacists that the Pharmacovigilance Center received their reports and their reports were utilized were also important.
format Online
Article
Text
id pubmed-8919562
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89195622022-03-16 Consumers’ adverse drug event reporting via community pharmacists: three stakeholder perception Kitisopee, Tanattha Assanee, Jirunya Sorofman, Bernard A. Watcharadmrongkun, Suntaree J Pharm Policy Pract Research BACKGROUND: Adverse drug event (ADE) reporting is a significant process to increase consumer care and consumer safety associated with the use of medicines. An in-depth investigation into low ADE reporting by consumers and community pharmacists was undertaken to uncover interventions to improve reporting. METHOD: In-depth interviewing of the three parties; consumers, pharmacists and employees of the Pharmacovigilance Center in Thailand, was used to collect the data. They were interviewed about ADE reporting experiences and contributing factors and problems of ADE reporting. Thematic analysis was used to interpret the results. RESULT: The HPVC received few ADE reports from consumers. Most community pharmacists received ADE reports from consumers; however, the Pharmacovigilance Center received few ADE reports from community pharmacists. ADE reporting of community pharmacists and consumers were influenced by many factors which were categorized into four themes which were (1) “Cognition” (awareness, attitude and responsibility); (2) “Reporting process” (complication, competency, information deficiency, feedback, and resource); (3) “Inducer” (service orientation, acquaintanceship, motivation, severity level, regulatory and reward); and (4) “Obstacle” (doubt, belief and prosecution). CONCLUSION: Health professionals should motivate consumers to report ADEs. Building social responsibility and benefits and increasing knowledge of reporting process, channels, and system to both community pharmacists and consumers were recommended. Providing rewards and making community pharmacists feel comfortable to report ADEs by simplifying the ADE form and providing training, guidelines, and an ADR assessment tool can drive them to report ADEs. Feedback to consumers by confirming whether it was ADE and feedback to pharmacists that the Pharmacovigilance Center received their reports and their reports were utilized were also important. BioMed Central 2022-03-14 /pmc/articles/PMC8919562/ /pubmed/35287746 http://dx.doi.org/10.1186/s40545-022-00417-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Kitisopee, Tanattha
Assanee, Jirunya
Sorofman, Bernard A.
Watcharadmrongkun, Suntaree
Consumers’ adverse drug event reporting via community pharmacists: three stakeholder perception
title Consumers’ adverse drug event reporting via community pharmacists: three stakeholder perception
title_full Consumers’ adverse drug event reporting via community pharmacists: three stakeholder perception
title_fullStr Consumers’ adverse drug event reporting via community pharmacists: three stakeholder perception
title_full_unstemmed Consumers’ adverse drug event reporting via community pharmacists: three stakeholder perception
title_short Consumers’ adverse drug event reporting via community pharmacists: three stakeholder perception
title_sort consumers’ adverse drug event reporting via community pharmacists: three stakeholder perception
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919562/
https://www.ncbi.nlm.nih.gov/pubmed/35287746
http://dx.doi.org/10.1186/s40545-022-00417-z
work_keys_str_mv AT kitisopeetanattha consumersadversedrugeventreportingviacommunitypharmaciststhreestakeholderperception
AT assaneejirunya consumersadversedrugeventreportingviacommunitypharmaciststhreestakeholderperception
AT sorofmanbernarda consumersadversedrugeventreportingviacommunitypharmaciststhreestakeholderperception
AT watcharadmrongkunsuntaree consumersadversedrugeventreportingviacommunitypharmaciststhreestakeholderperception